Want to join the conversation?
$IPXL said that it has received U.S. FDA's final approval for its generic version of Avodart (Dutasteride) capsules 0.5 mg on Nov. 20, 2015, which is used to treat benign prostatic hyperplasia in men with enlarged prostate. According to IMS Health, U.S. brand & generic sales of Dutasteride were about $457MM for 12 months ended Sept. 2015.
$MON shares dip slightly; I wonder this is because of the environmental lawsuit filed by the Washington state against the production of PCBs.
My bet is that $FR will reach $32 in the short term. It’s time it broke the 52-week high and had its fair share of growth.
$WYNN got bruised up by China after its decision to cut withdrawal limit in Macau ATMs. Wynn Resorts shares went down by more than 11%! Well who could have guessed that right?
$AVGO 4Q results beat analyst’s expectations again this time. Time to make some hay while the sun shines ;)